{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:44:55Z","timestamp":1793407495689,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T00:00:00Z","timestamp":1752969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T00:00:00Z","timestamp":1752969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Health Fellowship Foundation","award":["2023"],"award-info":[{"award-number":["2023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics Open"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s41669-025-00593-z","type":"journal-article","created":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T15:25:02Z","timestamp":1753025102000},"page":"793-804","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Economic Evaluation of Lecanemab for Early Symptomatic Alzheimer's Disease in South Korea"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7273-9447","authenticated-orcid":false,"given":"Seungyeon","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4618-4760","authenticated-orcid":false,"given":"Maryanne","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5188-9837","authenticated-orcid":false,"given":"Song Hee","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,20]]},"reference":[{"key":"593_CR1","unstructured":"Korean dementia observatory 2023. Natl Inst Dement. Available from: https:\/\/ansim.nid.or.kr\/community\/pds_view.aspx?page=&BID=. Accessed 15 Jun 2025."},{"key":"593_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2023.100865","author":"TLRH-W Pacific","year":"2023","unstructured":"Pacific TLRH-W. South Korea\u2019s population shift: challenges and opportunities. Lancet Reg Health. 2023. https:\/\/doi.org\/10.1016\/j.lanwpc.2023.100865.","journal-title":"Lancet Reg Health."},{"issue":"3","key":"593_CR3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.17340\/jkna.2018.3.3","volume":"36","author":"H Choi","year":"2018","unstructured":"Choi H, Kim SH, Lee J-H, Lee AY, Park KW, Lee EA, Choi SH, Na DL, Jeong JH. National responsibility policy for dementia care: current and future. J Korean Neurol Assoc. 2018;36(3):152\u20138. https:\/\/doi.org\/10.17340\/jkna.2018.3.3.","journal-title":"J Korean Neurol Assoc"},{"issue":"10","key":"593_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, Bohr VA. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15(10):565\u201381. https:\/\/doi.org\/10.1038\/s41582-019-0244-7.","journal-title":"Nat Rev Neurol"},{"key":"593_CR5","doi-asserted-by":"publisher","unstructured":"Miculas DC, Negru PA, Bungau SG, Behl T, Hassan ul SS, Tit DM. Pharmacotherapy evolution in Alzheimer\u2019s disease: current framework and relevant directions. Cells. 2023;12(1):131. 1-8  https:\/\/doi.org\/10.3390\/cells12010131.","DOI":"10.3390\/cells12010131"},{"issue":"1","key":"593_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH Van Dyck","year":"2023","unstructured":"Van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, Froelich L, Katayama S, Sabbagh M, Vellas B, Watson D, Dhadda S, Irizarry M, Kramer LD, Iwatsubo T. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388(1):9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948.","journal-title":"N Engl J Med"},{"key":"593_CR7","doi-asserted-by":"crossref","unstructured":"J\u00f6nsson L, Wimo A, Handels R, Johansson G, Boada M, Engelborghs S, Fr\u00f6lich L, Jessen F, Kehoe PG, Kramberger M, Mendon\u03c2a A de, Ousset PJ, Scarmeas N, Visser PJ, Waldemar G, Winblad B. The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer\u2019s disease: an EADC-EC viewpoint. Lancet Reg Health Eur 2023;29:1\u20138. PMID:37251789.","DOI":"10.1016\/j.lanepe.2023.100657"},{"key":"593_CR8","volume-title":"Lecanemab for early Alzheimer\u2019s disease","author":"G Lin","year":"2023","unstructured":"Lin G, Whittington M, Wright A, Agboola F, Herron-Smith S, Pearson S. Lecanemab for early Alzheimer\u2019s disease. Boston: Institute for Clinical and Economic Review (ICER); 2023."},{"issue":"3","key":"593_CR9","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s40120-022-00373-5","volume":"11","author":"AA Tahami Monfared","year":"2022","unstructured":"Tahami Monfared AA, Tafazzoli A, Chavan A, Ye W, Zhang Q. The potential economic value of lecanemab in patients with early Alzheimer\u2019s disease using simulation modeling. Neurol Ther. 2022;11(3):1285\u2013307. https:\/\/doi.org\/10.1007\/s40120-022-00373-5.","journal-title":"Neurol Ther"},{"issue":"4","key":"593_CR10","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s40120-023-00492-7","volume":"12","author":"A Igarashi","year":"2023","unstructured":"Igarashi A, Azuma MK, Zhang Q, Ye W, Sardesai A, Folse H, Chavan A, Tomita K, Tahami Monfared AA. Predicting the societal value of lecanemab in early Alzheimer\u2019s disease in Japan: a patient-level simulation. Neurol Ther. 2023;12(4):1133\u201357. https:\/\/doi.org\/10.1007\/s40120-023-00492-7.","journal-title":"Neurol Ther"},{"issue":"9","key":"593_CR11","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.18553\/jmcp.2023.29.9.1078","volume":"29","author":"AC Wright","year":"2023","unstructured":"Wright AC, Lin GA, Whittington MD, Agboola F, Herron-Smith S, Rind D, Pearson SD. The effectiveness and value of lecanemab for early Alzheimer disease: a summary from the Institute for Clinical and Economic Review\u2019s California Technology Assessment Forum. J Manag Care Spec Pharm. 2023;29(9):1078\u201383. https:\/\/doi.org\/10.18553\/jmcp.2023.29.9.1078.","journal-title":"J Manag Care Spec Pharm"},{"key":"593_CR12","unstructured":"Lee S, Han S, Ahn B, Park J, Jin D. Analysis of Healthcare Utilization in Dementia Patients. Health Insurance Review & Assessment Service, Republic of Korea; 2018 Dec. Available from: https:\/\/repository.hira.or.kr\/handle\/2019.oak\/1531. Accessed 15 Jan 2025."},{"issue":"1","key":"593_CR13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1186\/s12877-021-02526-x","volume":"21","author":"C Shon","year":"2021","unstructured":"Shon C, Yoon H. Health-economic burden of dementia in South Korea. BMC Geriatr. 2021;21(1):549. https:\/\/doi.org\/10.1186\/s12877-021-02526-x.","journal-title":"BMC Geriatr"},{"issue":"1","key":"593_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.12779\/dnd.2022.21.1.42","volume":"21","author":"JS Lee","year":"2022","unstructured":"Lee JS, Kim GH, Kim H-J, Kim HJ, Na S, Park KH, Park YH, Suh J, Shin JH, Oh S, Yoon B, Rhee HY, Lim J-S, Jang J-W, Chin J, Hong YJ, Shim Y, Association KD. Clinical Practice Guideline for Dementia (Diagnosis and Evaluation): 2021 revised edition. Dement Neurocognitive Disord. 2022;21(1):42\u20134. https:\/\/doi.org\/10.12779\/dnd.2022.21.1.42.","journal-title":"Dement Neurocognitive Disord"},{"issue":"6","key":"593_CR15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s40273-021-01112-8","volume":"40","author":"D Husereau","year":"2022","unstructured":"Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, Caulley L, Chaiyakunapruk N, Greenberg D, Loder E, Mauskopf J, Mullins CD, Petrou S, Pwu R-F, Staniszewska S. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations. Pharmacoeconomics. 2022;40(6):601\u20139. https:\/\/doi.org\/10.1007\/s40273-021-01112-8.","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"593_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4235\/agmr.20.0082","volume":"25","author":"H Jun","year":"2021","unstructured":"Jun H, Cho SK, Yoong J, Mattke S. Is korea prepared for an Alzheimer\u2019s disease-modifying therapy? Assessing the Korean Healthcare System Infrastructure and the Effect of Blood-Based Biomarker Tests. Ann Geriatr Med Res. 2021;25(1):33\u20138. https:\/\/doi.org\/10.4235\/agmr.20.0082.","journal-title":"Ann Geriatr Med Res"},{"key":"593_CR17","doi-asserted-by":"publisher","unstructured":"Park B, Lee TJ, Lee Y-S, Jang S, Choi N, Jeong H-G, Han J, Yang H. Cost of Illness and Quality of Life of Patients and Their Caregivers with Mild Cognitive Impairment or Alzheimer's Disease. J Health Technol Assess 2019;7(1):62-74. https:\/\/doi.org\/10.34161\/johta.2019.7.1.00718. Survey Report of the Elderly with Dementia. Seoul National University Bundang Hospital; 2011. Report No.: 11-1351000-000589\u201301. Available from: https:\/\/www.prism.go.kr\/homepage\/entire\/researchDetail.do?researchId=1351000-201000126&gubun=totalSearch&menuNo=I0000002. Accessed 26 Jan 2025.","DOI":"10.34161\/johta.2019.7.1.00718"},{"issue":"3","key":"593_CR18","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3988\/jcn.2019.15.3.334","volume":"15","author":"T-J Song","year":"2019","unstructured":"Song T-J, Lee MJ, Choi Y-J, Kim B-K, Chung P-W, Park J-W, Chu MK, Kim B-S, Sohn J-H, Oh K, Kim D, Kim J-M, Kim S-K, Park K-Y, Chung JM, Moon H-S, Chung C-S, Ahn J-Y, Cho S-J. Differences in characteristics and comorbidity of cluster headache according to the presence of migraine. J Clin Neurol. 2019;15(3):334\u20138. https:\/\/doi.org\/10.3988\/jcn.2019.15.3.334.","journal-title":"J Clin Neurol"},{"key":"593_CR19","unstructured":"Guidelines for economic evaluation of pharmaceuticals. 2021. Available from: https:\/\/www.hira.or.kr\/bbsDummy.do?pgmid=HIRAA020002000100&brdScnBltNo=4&brdBltNo=8661. Accessed 20 Aug 2023."},{"issue":"6","key":"593_CR20","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1212\/WNL.52.6.1138","volume":"52","author":"PJ Neumann","year":"1999","unstructured":"Neumann PJ, Hermann RC, Kuntz KM, Araki SS, Duff SB, Leon J, Berenbaum PA, Goldman PA, Williams LW, Weinstein MC. Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer\u2019s disease. Neurology. 1999;52(6):1138\u20131138. https:\/\/doi.org\/10.1212\/WNL.52.6.1138.","journal-title":"Neurology"},{"issue":"2","key":"593_CR21","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s40120-021-00273-0","volume":"10","author":"WL Herring","year":"2021","unstructured":"Herring WL, Gould IG, Fillit H, Lindgren P, Forrestal F, Thompson R, Pemberton-Ross P. Predicted lifetime health outcomes for aducanumab in patients with early Alzheimer\u2019s disease. Neurol Ther. 2021;10(2):919\u201340. https:\/\/doi.org\/10.1007\/s40120-021-00273-0.","journal-title":"Neurol Ther"},{"key":"593_CR22","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.trci.2019.06.005","volume":"5","author":"JS Andrews","year":"2019","unstructured":"Andrews JS, Desai U, Kirson NY, Zichlin ML, Ball DE, Matthews BR. Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer\u2019s disease clinical trials. Alzheimers Dement (N Y). 2019;5:354\u201363.","journal-title":"Alzheimers Dement (N Y)."},{"key":"593_CR23","unstructured":"Life Tables. Korean Stat Inf Serv Repub Korea. Available from: https:\/\/kosis.kr\/common\/meta_onedepth.jsp?vwcd=MT_ZTITLE&listid=F_29. Accessed 15 Jan 2025."},{"issue":"12","key":"593_CR24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3390\/bs12120471","volume":"12","author":"S Fukuda","year":"2022","unstructured":"Fukuda S, Lal S, Katauke T, Khan MSR, Kadoya Y. Impact of changing socioeconomic conditions on family caregiving norms: evidence from Japan. Behav Sci (Basel). 2022;12(12):471. https:\/\/doi.org\/10.3390\/bs12120471.","journal-title":"Behav Sci (Basel)."},{"issue":"5","key":"593_CR25","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/nur.20031","volume":"27","author":"HS Kang","year":"2004","unstructured":"Kang HS, Jeon WJ. A thematic analysis of Korean family caregivers\u2019 experiences in making the decision to place a family member with dementia in a long-term care facility. Res Nurs Health. 2004;27(5):345\u201356. https:\/\/doi.org\/10.1002\/nur.20031.","journal-title":"Res Nurs Health"},{"key":"593_CR26","unstructured":"EISAI\u2019S APPROACH TO U.S. PRICING FOR LEQEMBITM (LECANEMAB), A TREATMENT FOR EARLY ALZHEIMER\u2019S DISEASE, SETS FORTH OUR CONCEPT OF \u201cSOCIETAL VALUE OF MEDICINE\u201d IN RELATION TO \u201cPRICE OF MEDICINE\u201d | News Release: 2023. Eisai Co Ltd. Available from: https:\/\/www.eisai.com\/news\/2023\/news202302.html. Accessed 15 Jan 2025."},{"key":"593_CR27","unstructured":"Average weight distribution by age and gender. Korean Stat Inf Serv Repub Korea. Available from: https:\/\/kosis.kr\/statHtml\/statHtml.do?sso=ok&returnurl=https%3A%2F%2Fkosis.kr%3A443%2FstatHtml%2FstatHtml.do%3FtblId%3DDT_35007_N132%26orgId%3D350%26. Accessed 26 Jan 2025."},{"key":"593_CR28","unstructured":"Health Insurance Medical Care Benefits. Health Insurance Review & Assessment Service, Republic of Korea: Health Insurance Review & Assessment Service, Republic of Korea; 2023. Available from: https:\/\/repository.hira.or.kr\/handle\/2019.oak\/3076. Accessed 15 Jan 2025."},{"key":"593_CR29","unstructured":"National Health Insurance Service. Available from: https:\/\/nhiss.nhis.or.kr\/en\/z\/a\/011\/lpza011m01en.do. Accessed 15 Jan 2025."},{"key":"593_CR30","unstructured":"Statistics Korea. Population by Age and Sex (Annual). KOSIS. https:\/\/kosis.kr\/statHtml\/statHtml.do?orgId=101&tblId=DT_1J22003. Published 2024. Accessed 15 June 2025."},{"key":"593_CR31","unstructured":"Ministry of Health and Welfare Notification No. 2018 - 198. Oct 1, 2018. Available from: https:\/\/www.mohw.go.kr\/board.es?mid=a10409020000&bid=0026&act=view&list_no=346138&tag=&nPage=238. Accessed 26 Jan 2025."},{"key":"593_CR32","unstructured":"Clinics 225%\u2191 - Hospitals 139%\u2191 after applying MRI scan health insurance. Yakup; 2019 Oct 11; Available from: http:\/\/m.yakup.com\/news\/index.html?nid=235922&mode=view. Accessed 26 Jan 2025."},{"key":"593_CR33","unstructured":"Information on ICERs for drugs submitted for economic evaluation. Health Insur Rev Assess Serv Repub Korea. 2022. Available from: https:\/\/www.hira.or.kr\/bbsDummy.do?pgmid=HIRAA020002000100&brdScnBltNo=4&brdBltNo=10021&pageIndex=1. Accessed 2 Jan 2024."},{"key":"593_CR34","unstructured":"DESIGNPIXEL. Comparison of drug prices across 33 OECD countries, including the US, Korea, and others. KoreaBio. Available from: https:\/\/www.koreabio.org\/board\/board.php?bo_table=report&idx=71. Accessed 26 Jan 2025."},{"key":"593_CR35","unstructured":"Announcement of revision of \u201cDrug Price Negotiation Guidelines\u201d and \u201cDetailed Operating Guidelines for Risk Sharing Drug Price Negotiation.\u201d Natl Health Insur Serv. 2024. Available from: https:\/\/www.nhis.or.kr\/nhis\/together\/wbhaea02200m01.do?mode=view&articleNo=10848377. Accessed 26 Jan 2025."},{"key":"593_CR36","doi-asserted-by":"publisher","unstructured":"Performance-based managed entry agreements for new medicines in OECD countries and EU member states: How they work and possible improvements going forward. 2019 Dec. Report No.: 115. https:\/\/doi.org\/10.1787\/6e5e4c0f-en","DOI":"10.1787\/6e5e4c0f-en"},{"issue":"1","key":"593_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.15280\/jlm.2016.6.1.16","volume":"6","author":"Y Dronina","year":"2016","unstructured":"Dronina Y, Yoon YM, Sakamaki H, Nam EW. Health system development and performance in Korea and Japan: a comparative study of 2000?2013. J Lifestyle Med. 2016;6(1):16\u201326. https:\/\/doi.org\/10.15280\/jlm.2016.6.1.16.","journal-title":"J Lifestyle Med"},{"issue":"8","key":"593_CR38","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.jalz.2018.03.009","volume":"14","author":"T Iwatsubo","year":"2018","unstructured":"Iwatsubo T, Iwata A, Suzuki K, Ihara R, Arai H, Ishii K, Senda M, Ito K, Ikeuchi T, Kuwano R, Matsuda H, Sun C-K, Beckett LA, Petersen RC, Weiner MW, Aisen PS, Donohue MC. Japanese and North American Alzheimer\u2019s Disease Neuroimaging Initiative studies: Harmonization for international trials. Alzheimers Dement. 2018;14(8):1077\u201387. https:\/\/doi.org\/10.1016\/j.jalz.2018.03.009.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"593_CR39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13195-022-01124-2","volume":"14","author":"E McDade","year":"2022","unstructured":"McDade E, Cummings JL, Dhadda S, et al. Lecanemab in patients with early Alzheimer\u2019s disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study. Alzheimer\u2019s Res Ther. 2022;14(1):191. https:\/\/doi.org\/10.1186\/s13195-022-01124-2.","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"7_Supplement_1","key":"593_CR40","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1212\/WNL.0000000000211489","volume":"104","author":"M Irizarry","year":"2025","unstructured":"Irizarry M, van Dyck C, Li D, et al. The lecanemab clarity AD open-label extension in early Alzheimer\u2019s disease (P1\u20133.003). Neurology. 2025;104(7_Supplement_1):4158. https:\/\/doi.org\/10.1212\/WNL.0000000000211489.","journal-title":"Neurology"},{"issue":"12","key":"593_CR41","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jval.2019.07.002","volume":"22","author":"A Martin","year":"2019","unstructured":"Martin A, Meads D, Griffiths AW, Surr CA. How should we capture health state utility in dementia? comparisons of DEMQOL-Proxy-U and of Self- and proxy-completed EQ-5D-5L. Value Health. 2019;22(12):1417\u201326 (PMID:31806199).","journal-title":"Value Health"},{"issue":"2","key":"593_CR42","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s11136-019-02333-3","volume":"29","author":"AW Griffiths","year":"2020","unstructured":"Griffiths AW, Smith SJ, Martin A, Meads D, Kelley R, Surr CA. Exploring self-report and proxy-report quality-of-life measures for people living with dementia in care homes. Qual Life Res. 2020;29(2):463\u201372. https:\/\/doi.org\/10.1007\/s11136-019-02333-3.","journal-title":"Qual Life Res"},{"issue":"2","key":"593_CR43","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3233\/JAD-190426","volume":"70","author":"YH El-Hayek","year":"2019","unstructured":"El-Hayek YH, Wiley RE, Khoury CP, Daya RP, Ballard C, Evans AR, Karran M, Molinuevo JL, Norton M, Atri A. Tip of the iceberg: assessing the global socioeconomic costs of alzheimer\u2019s disease and related dementias and strategic implications for stakeholders. J Alzheimer\u2019s Dis. 2019;70(2):323\u201341. https:\/\/doi.org\/10.3233\/JAD-190426.","journal-title":"J Alzheimer\u2019s Dis"}],"container-title":["PharmacoEconomics - Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41669-025-00593-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41669-025-00593-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41669-025-00593-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:52:44Z","timestamp":1757260364000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41669-025-00593-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,20]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["593"],"URL":"https:\/\/doi.org\/10.1007\/s41669-025-00593-z","relation":{},"ISSN":["2509-4262","2509-4254"],"issn-type":[{"value":"2509-4262","type":"print"},{"value":"2509-4254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,20]]},"assertion":[{"value":"9 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Affiliation 3, assigned to the author Maryanne Kim, was given incorrectly as \"Division of Geriatrics, University of California,\nSan Francisco, CA, USA\" and has now been corrected to \"Division of Geriatrics, University of California San Francisco, San Francisco, CA, USA\".","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Seungyeon Shin and Maryanne Kim contributed equally to this work. Conceptualization and design: Shin, Kim, and Hong. Data acquisition, analysis, and interpretation: Shin and Hong. Statistical analysis: Shin and Kim. Writing original draft: Shin, Kim, and Hong. Writing review and editing: Shin, Kim, and Hong. Critical revision of the article for important intellectual content: Shin, Kim, and Hong. Obtaining funding: Shin. Supervision: Hong.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}},{"value":"This study was funded and supported by 2023 Health Fellowship Foundation of South Korea.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare they have no conflicts of interest relevant to the contents of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest:"}},{"value":"This study was reviewed and approved by the Seoul National University Institutional Review Board, # 2305\/003-009.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"All model inputs analyzed during this study are included in this published article.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"Model developed for this study is available at .","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}]}}